SecBot SecBot
Insider Cluster (3 insiders) ·Filed Apr 9, 2026

DNA

Ginkgo Bioworks Holdings, Inc.
BEARISH
Impact 6/10
Horizondays Processed7mo ago
Insider cluster: 3 insiders, $0.9M total
Actionable Insight ▼ Bearish

Traders should watch for further selling pressure or negative news catalysts; the concentration of sales among key insiders, especially a 10% owner, may signal reduced confidence in near-term prospects. Monitor upcoming earnings or pipeline updates.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$6.43
T+0 close · Apr 8, 2026 · via day close
Latest settled
+57.23%
T+60 · $10.11
Vs SPY
+46.45%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 9 $6.43entry
  2. T+1 · 7mo ago +0.31%α +0.37% · $6.45
  3. T+5 · 7mo ago +23.64%α +20.45% · $7.95
  4. T+20 · 6mo ago +56.77%α +49.20% · $10.08
  5. T+60 · 4mo ago +57.23%α +46.45% · $10.11
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three corporate insiders at Ginkgo Bioworks (DNA) conducted open-market share sales over a 7-day period, totaling approximately $870,000 in value. The sales were led by Kelly Jason R, who sold $702K worth of stock, while Shetty Reshma P. and Canton Barry each sold around $84K. These transactions follow larger derivative exercises and sales earlier in the week, indicating a coordinated reduction in holdings.

Key Financial Metrics

Direction
selling
Total Value
$870.0K
Insiders
3

Key Facts

  • Insider cluster involves three individuals: Kelly Jason R, Shetty Reshma P., and Canton Barry (10% owner).
  • Total open-market sales amount to $870,000 over 7 days, with Kelly Jason R accounting for the majority ($702K).
  • Concurrent with multiple non-cash derivative exercises (code M), suggesting option expirations or vesting events.
  • Total selling value represents ~0.22% of DNA's $399M market cap, modest but notable for a small-cap biotech.
  • Sales occurred at prices between $6.397 and $6.93 per share, with average execution near $6.40.

Financial Impact

$870,000 in insider selling over 7 days (~0.22% of market cap)

insider ownershipmarket sentimentdilution perception

Risk Factors

  • Perception of insider pessimism, particularly from a 10% owner
  • Potential for follow-on selling or negative sentiment in a low-liquidity OTC stock

Market Snapshot

Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-DNA-1776114053074

Track record

7 reports on DNA

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 5, 202611d ago 8-K Neutral 5/10 Entry $11.29 Now $8.50 −24.71% settles Feb 4
  2. Oct 29, 202618d ago 8-K Neutral 2/10 Entry $11.21 Now $8.50 −24.17% settles Jan 28
  3. Oct 21, 202626d ago Insider Cluster Neutral 2/10 Entry $9.71 Now $8.50 −12.46% settles Jan 20
  4. Oct 19, 202628d ago 144 Neutral 2/10 Entry $10.07 Now $8.50 −15.59% settles Jan 14
  5. Sep 15, 20268w ago 144 Neutral 2/10 Entry $6.99 Now $8.50 +21.60% settles Dec 9
  6. Apr 9, 202631w ago Insider Cluster Bearish 6/10 Entry $6.43 to $10.11 Now $8.50 −32.19% ▼ −57.23% −46.45% vs SPY
  7. Apr 9, 202631w ago Insider Cluster Bearish 6/10 Viewing Entry $6.43 to $10.11 Now $8.50 −32.19% ▼ −57.23% −46.45% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens in 6h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 13, 2026